[18F]FES PET/CT in Endocrine Refractory Breast Cancer

Clinical trial NCT02409316 · TERMINATED

Trial details

NCT number: NCT02409316
Sponsor: University of Pennsylvania
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor Positive Breast Cancer Breast Neoplasm Metastatic Breast Cancer

Start date: 2015-10-15
Primary completion: 2025-08-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.